Frank Pallone actually said...

the imbalance of inspection requirements between U.S. and foreign manufacturing facilities creates an uneven playing field for pharmaceutica...

Thank you. Now, would it be helpful to have additional resources to conduct more foreign inspections of brand facilities?

As you know, Mr. Dingell, Ms. DeGette, myself, and Mr. Waxman have introduced the Drug Safety Enhancement Act that gives the FDA authorities...

We are going to move forward with them.